Sort
15,273 grants matching “antimicrobial resistance”
Mechanism of a hypothiocyanous acid reductase
$558,493Frederick Stull · Western Michigan University · R15 · FY2025 · GM
The molecular basis of epidemic blaKPC Klebsiella pneumoniae and Enterobacteriace
$558,370Barry Neal Kreiswirth · Univ Of Med/Dent Of Nj-Nj Medical School · R56 · FY2010 · AI
Mitochondrial Dynamics in RPE Homeostasis and Disease
$558,273Scott M Plafker · Oklahoma Medical Research Foundation · R01 · FY2020 · EY
Synthetic and translational studies of antitumor and antimicrobial natural products
$558,237Seth B. Herzon · Yale University · R35 · FY2019 · GM
Quinolone resistant E coli in long term care facilities
$558,147Ebbing Lautenbach · University Of Pennsylvania · R01 · FY2009 · AG
Characterization of Rifabutin Therapy Against Antibiotic-Resistant Bacteria
$558,043Brian Michael Luna · University Of Southern California · R01 · FY2020 · AI
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
$557,858Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2019 · AI
Characterization of Rifabutin Therapy Against Antibiotic-Resistant Bacteria
$557,835Brian Michael Luna · University Of Southern California · R01 · FY2018 · AI
Characterization of Rifabutin Therapy Against Antibiotic-Resistant Bacteria
$557,606Brian Michael Luna · University Of Southern California · R01 · FY2021 · AI
Mucin Glycans in the Regulation of Microbial Virulence
$557,507Katharina Ribbeck · Massachusetts Institute Of Technology · R01 · FY2021 · EB
Structural dynamics of RNAP-promoter complex in late transcription initiation
$557,505Shimon Weiss · University Of California Los Angeles · R01 · FY2019 · GM
Lactoferrin Enhances Growth and Reduces Nosocomial Infection in Preterm Infants
$557,320Karel Petrak · Agennix, Inc. · R44 · FY2008 · HD
Pharmacologic Approaches to Combating Resistance to Antimalarial Combinations
$557,200David Armand Fidock · Columbia University Health Sciences · R01 · FY2011 · AI
Host-mediated zinc sequestration during Acinetobacter baumannii infection
$557,036Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2019 · AI
Molecular Analysis of Host Immune Response in Leprosy
$556,923Robert L Modlin · University Of California Los Angeles · R01 · FY2017 · AI
Molecular Analysis of Host Immune Response in Leprosy
$556,923Robert L Modlin · University Of California Los Angeles · R01 · FY2016 · AI
Antimicrobial Resistance in Bacteria
$556,890Stanley N Cohen · Stanford University · R01 · FY2011 · AI
Biomarkers for Urinary Tract Infection and Pyelonephritis
$556,694Nader Shaikh · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Mode of Action Core
$556,400Bruce Steven Klein · University Of Wisconsin-Madison · U19 · FY2019 · AI
Redefining the role of autophagy in bacterial disease
$556,377Ken Hashigiwa Cadwell · New York University School Of Medicine · R01 · FY2017 · AI
RNA modification and antibiotic resistance
$556,322Graeme L Conn · Emory University · R01 · FY2020 · AI
Nanotechnology Based Infection Control for Ventricular Assist Devices
$556,284Sang Beom Lee · Nanodynamics Life Sciences, Inc. · R44 · FY2011 · HL
Ag-specific gamma delta T cells and immunity to TB/AIDS-related TB
$556,180Zheng W Chen · University Of Illinois At Chicago · R01 · FY2014 · OD
Vaccine and Treatment Evaluation Units
$556,000Nadine Georges Rouphael · Emory University · UM1 · FY2020 · AI
Improving PrEP outcomes among pregnant women in Botswana with an integrated STI testing and PrEP delivery model
$555,945Chelsea Morroni · Botswana-Harvard Aids Institute · R01 · FY2025 · HD